Alere Wellbeing Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT01087905
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Alere, Inc. | Alere Wellbeing

Active Ingredients

Drugs in Phase 4 Trials (1)

nicotine (nicorette) (2 trials)

Drugs in Other Trials (2)

sacubitril (Entresto) (1 trial)

valsartan (diovan) (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3